BioSpace News Archive

Feb. 21, 2018 13:00 UTC The Compendium provides scientists an online resource to help design efficient in vitro and in vivo oncology research studies

The global market for monoclonal antibodies (mAbs) - large protein molecules produced by white blood cells that seek out and destroy harmful foreign substances - topped $100 billion in 2017, according to Kalorama Information.

Pharmaceutical Product Development, LLC (PPD) today announced it has been honored for employee learning and development programs that help the global contract research organization deliver service excellence to its pharmaceutical and biotechnology clients.

New plasmid to reduce cost and timeline for gene therapy manufacturing.

Aesculap, Inc. is pleased to announce the asset acquisition of Dextera Surgical Inc.

Biologics, Inc., a McKesson Specialty Health oncology and complex care pharmacy services company, has been selected by the Janssen Pharmaceutical Companies of Johnson & Johnson to be in the limited distribution network for ERLEADA™ (apalutamide), the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer (NM-CRPC).

Glenmark Pharmaceuticals, a global pharmaceutical company, today announced it has entered into an exclusive agreement with Sam Chun Dang Pharm. Co. Ltd. (SCD), to develop, manufacture and market a portfolio of ophthalmic products in the U.S. and Canada.

Endologix, Inc. announced today that John McDermott is stepping down as the Company’s Chief Executive Officer.

Insulet Corporation today announced financial results for the three months and full year ended December 31, 2017.

bluebird bio, Inc. today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2017.